Summit Agenda
Advancing Excellence in Castleman’s Disease Care
Wednesday, December 2, 2009
Wyndham Riverfront New Orleans
download pdf of agenda
9:00 am Summit registration / continental breakfast
10:00 am Welcome and introductions
- Jim Johnston, Founder and Executive Director, International Castleman’s Disease Organization
- David Golub, Vice President, Mark Krueger & Associates, Inc.
10:15 am Living with Castleman’s Disease: A Patient Perspective
- Razelle Kurzrock, MD, FACP, Chair and Professor, Department of Investigational Cancer Therapeutics; Anderson Clinical Faculty Chair for Cancer Treatment and Research, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center
- Wayne Hook, Castleman’s Disease patient
11:00 am Understanding Castleman’s Disease: Epidemiology, Histology and Diagnosis
- Guido Tricot, MD, PhD, Director, Stem Cell Transplant and Myeloma Program, University of Utah School of Medicine
11:45 am Treating and Managing Castleman’s Disease
- Frits van Rhee, MD, PhD, MRCP (UK), FRCPath, Professor of Medicine, Director of Clinical Research, Myeloma Institute for Research and Therapy, University of Arkansas Medical Sciences
12:30 pm Luncheon service
1:15 pm An Introduction to the Rare Disease Advocacy Community
- Jean Campbell, Vice President of Membership Development, National Organization for Rare Disorders (NORD)
2:00 pm Break
2:15 pm Panel Discussion: Advancing Excellence in Castleman’s Disease Care
Panelists:
- Corey Casper, MD, MPH, Associate Professor of Medicine, Allergy & Infectious Diseases, Adjunct Associate Professor, Epidemiology and Global Health, University of Washington; Assistant Member, Vaccine and Infectious Diseases Institute, Director, Uganda Program on Cancer & Infectious Diseases, Fred Hutchinson Cancer Research Center
- H. Miles Prince, MBBS (Hons), MD, MRACMA, FRACP, FRCPA, Director, Centre for Blood Cell Therapies, Peter MacCallum Cancer Centre
- Jean-Francois Rossi, MD, PhD, Department Head, Hematology and Medical Oncology, CHU Saint Eloi, Montpellier
Moderator:
- David Golub, Vice President, Mark Krueger and Associates, Inc.
3:30 pm Making a Difference in Castleman’s Disease Care
- Greg Pacheco, Castleman’s Disease patient
4:00 pm Concluding Remarks
4:15–6:00 pm Networking Reception
